Enhancement of p53-mutant human colorectal cancer cells radiosensitivity by flavonoid fisetin

International Journal of Radiation Oncology, Biology, Physics
Wen-Shu ChenShu-Jun Chiu

Abstract

The aim of this study was to investigate whether fisetin is a potential radiosensitizer for human colorectal cancer cells, which are relatively resistant to radiotherapy. Cell survival was examined by clonogenic survival assay, and DNA fragmentation was assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay. The effects of treatments on cell cycle distribution and apoptosis were examined by flow cytometry. Western blot analysis was performed to ascertain the protein levels of gamma-H2AX, phospho-Chk2, active caspase-3, PARP cleavage, phospho-p38, phospho-AKT, and phospho-ERK1/2. Fisetin pretreatment enhanced the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells but not human keratocyte HaCaT cells; it also prolonged radiation-induced G(2)/M arrest, enhanced radiation-induced cell growth arrest in HT-29 cells, and suppressed radiation-induced phospho-H2AX (Ser-139) and phospho-Chk2 (Thr-68) in p53-mutant HT-29 cells. Pretreatment with fisetin enhanced radiation-induced caspase-dependent apoptosis in HT-29 cells. Fisetin pretreatment augmented radiation-induced phosphorylation of p38 mitogen-activated protein kinase, which is involved in caspase-mediated apoptosis, and SB202190 si...Continue Reading

References

May 1, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M OmuraN Kubota
Apr 16, 1998·The Journal of Biological Chemistry·E P RogakouW M Bonner
Jan 12, 2000·Archives of Disease in Childhood·D Hall
Jan 1, 2003·The Surgical Clinics of North America·Leonard B Saltz, Bruce Minsky
Jun 6, 2003·International Journal of Radiation Oncology, Biology, Physics·Anjali K GuptaW Gillies McKenna
Aug 30, 2003·Oncogene·Paul DentSteven Grant
Jul 6, 2004·International Journal of Radiation Oncology, Biology, Physics·Timothy M Pawlik, Khandan Keyomarsi
Feb 4, 2005·Journal of Medicinal Chemistry·Heshu LuUrsula Schulze-Gahmen
Nov 30, 2005·Prostate Cancer and Prostatic Diseases·A Q HaddadL H Klotz
Apr 8, 2006·International Archives of Allergy and Immunology·Toru HiranoToshio Tanaka
Jun 27, 2006·Investigative Ophthalmology & Visual Science·Anne HannekenPamela Maher
Jul 19, 2006·Nature Reviews. Genetics·Jeffrey A EngelmanLewis C Cantley
Jul 21, 2006·Cell Cycle·Michael Downey, Daniel Durocher
Oct 20, 2006·Proceedings of the National Academy of Sciences of the United States of America·Pamela MaherKazuho Abe
Jan 30, 2007·Nature Clinical Practice. Oncology·Tanguy Y SeiwertEverett E Vokes
Mar 17, 2007·Molecular Cancer Therapeutics·Kristoffer ValeriePaul Dent
Sep 13, 2007·Journal of Enzyme Inhibition and Medicinal Chemistry·Roberta R Ruela de SousaHiroshi Aoyama
Nov 16, 2007·Nature Reviews. Cancer·Laurent AntoniMichelle D Garrett
Feb 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Toshimitsu TanakaRaymond E Meyn
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jul 1, 2008·Gynecologic Oncology·Christa B FuhrmanKaren A Zempolich
Mar 7, 2009·American Journal of Physiology. Gastrointestinal and Liver Physiology·Do Y Lim, Jung Han Yoon Park

❮ Previous
Next ❯

Citations

Nov 6, 2012·Antioxidants & Redox Signaling·Naghma KhanHasan Mukhtar
Mar 2, 2011·Pharmacology & Therapeutics·Nam Joo KangKi Won Lee
Sep 12, 2015·Critical Reviews in Food Science and Nutrition·Tamara Y Forbes-HernandezMaurizio Battino
Jul 31, 2012·Biochemical Pharmacology·Vaqar Mustafa AdhamiHasan Mukhtar
May 11, 2016·Seminars in Cancer Biology·Deeba N SyedHasan Mukhtar
Apr 10, 2016·Molecular Nutrition & Food Research·Rahul K LallHasan Mukhtar
Oct 7, 2016·International Journal of Radiation Biology·Shin-Ichi BandoKen Ohnishi
Oct 21, 2018·Journal of Cancer Research and Clinical Oncology·Mahdi AbbasianDavid A Lightfoot
Apr 30, 2019·Frontiers in Immunology·Anna Maria MileoStefania Miccadei
Dec 17, 2014·ACS Applied Materials & Interfaces·Yishan ChenChangyang Gong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.